Bliss GVS Pharma Ltd. NSE: BLISSGVS | BSE: 506197

Strong Performer, Under Radar

Download real time

153.72 -0.53 (-0.34%)

44.96% Gain from 52W Low

25,728

NSE+BSE Volume

NSE 16 Jul, 2025 9:37 AM (IST)

Dividend

Bliss GVS Pharma Ltd. has an upcoming dividend of ₹0.50 per share due on 24 Jul 2025 See details

Bliss GVS Pharma Ltd. share price target

Name: Latest research reports of Bliss GVS Pharma Ltd. authored by Choice India and published by - Trendlyne research reports.
Item: Bliss GVS Pharma Ltd.
Rating: 5
Author: Choice India

Latest broker research reports with buy, sell, hold recommendations along with forecast share price targets and upside. Browse thousands of reports and search by company or the broker.

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	15 Mar 2018	Bliss GVS Pharma	Choice India	153.72	250.00	197.30 (-22.09%)		Buy	pdf post cache		Broker Report Bliss GVS Pharma Ltd Choice India The Company has established brand operations in existing markets that provide an ideal platform to extend the Bliss GVS product portfolio and with that, build new revenue streams. On the back of significant expansion across both Pharmaceutical & Healthcare verticals, the Company could be poised for an accelerated growth At CMP of Rs. 184.8 ,Bliss GVS Ltd. is trading at a P/E multiple of 12.8(x) compared to the industry peer of 25.2(x). The company has an upside potential of 25% to 30% in the next 12 to 18 months. We arrive at a target price in range of Rs231 to Rs.240.... pdf Copy Link Share on Share on Share on Share on Alert
	09 Jan 2018	Bliss GVS Pharma	Joindre Capital Services	153.72	350.00	206.95 (-25.72%)		Buy	pdf post cache		Broker Report BLISS GVS PHRMA LTD Joindre Capital Services Bliss GVS Pharma Ltd. is an Indian pharmaceutical company headquartered in Mumbai, India. Bgvsl primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.BGVSLis among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment. It has three decades of experience in suppositories and pessaries. BGVSL most unique product is Today Vaginal Contraceptive', a safe female contraceptive. It is the only EU-GMP certified suppositories and pessaries manufacturer in India. & its portfolio... pdf Copy Link Share on Share on Share on Share on Alert

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

44.96% Gain from 52W Low

Bliss GVS Pharma Ltd. share price target

Latest broker research reports with buy, sell, hold recommendations along with forecast share price targets and upside. Browse thousands of reports and search by company or the broker.

Bliss GVS Pharma Ltd

BLISS GVS PHRMA LTD

Advisor Screeners